Evidence map›Paper›PMID 41443760›Full record

ArticleBiostatistics (Oxford, England)2025

While-alive regression analysis of composite survival endpoints.

Xi Fang, Hajime Uno, Fan Li

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xi FangDepartment of Biostatistics, Yale School of Public Health, 60 College St, New Haven, CT 06510, United States.ORCID 0000-0002-6692-5730
Hajime UnoDepartment of Data Science, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, United States.ORCID 0000-0003-0622-8471
Fan LiDepartment of Biostatistics, Yale School of Public Health, 60 College St, New Haven, CT 06510, United States.ORCID 0000-0001-6183-1893

Funding

Randomized Trial of a Multifactorial Fall Injury Prevention Strategy-SupplementU01AG048270 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI BHASIN, SHALENDER, GILL, THOMAS MICHAEL · 2014 to 2019
$34.8M
Advancing the design, analysis, and interpretation of acute respiratory distress syndrome trials using modern statistical toolsR01HL168202 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Michael Oscar Harhay, Fan Li · 2023 to 2026
$2.9M
New win methods for addressing multiple and composite outcomes in cluster-randomized trialsR01HL178513 · NHLBI · YALE UNIVERSITY · PI Fan Li · 2025 to 2026
$1.4M
Survival Data Analysis using general censoring-free incident rateR01GM152499 · NIGMS · DANA-FARBER CANCER INST · PI Hajime Uno · 2024 to 2026
$1.0M
NHLBI NIH HHS R01 HL168202NHLBI NIH HHS R01-HL168202NHLBI NIH HHS R01 HL178513NHLBI NIH HHS R01-HL178513NIA NIH HHS U01 AG048270NIGMS NIH HHS R01 GM152499NIGMS NIH HHS R01GM152499
6 · The paper itself

Abstract

Composite endpoints are frequently used in clinical trials to enhance the event rate and improve the statistical power. In the presence of a terminal event, the while-alive cumulative frequency measure offers a useful alternative to define composite survival outcomes, by relating the average event rate to the survival time. Although non-parametric methods have been proposed for two-sample comparisons, limited attention has been given to regression methods that directly address time-varying association effects in while-alive measures. We address this gap by developing a regression framework for exposure-weighted while-alive measures for composite survival outcomes that include a terminal component event. Our regression approach uses splines to model time-varying association between covariates and a generalized while-alive loss rate of all component events, and can be applied to both independent and clustered data. We derive the asymptotic properties of the regression estimator under both independent data and cluster-correlated data settings, and study the operating characteristics of our methods through simulations. Finally, we apply our regression method to analyze data two randomized clinical trials. The proposed methods are implemented in the WAreg R package.

Indexed as

Endpoint DeterminationModels, StatisticalComputer SimulationData Interpretation, StatisticalHumansRandomized Controlled Trials as TopicRegression AnalysisSurvival Analysiscluster randomized trialscomposite outcomeinverse probability of censoring weightingrandomized clinical trialsrecurrent eventsplines

Identifiers

PMID41443760
PMCPMC12711255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.